Research lines

Click on a persons name for more information regarding his/her research

Medical Oncology research lines  

PI: Liesbeth de Vries, Head of the Department of Medical Oncology

PI: Steven de Jong

• Understanding chemosensitivity of testicular germ cell tumors
• Inducing apoptosis and inhibiting pro-survival to enhance drug efficacy in cancer

• Identifying novel drugable pathways in ovarian and cervical cancer

PI: Frank Kruyt  

• Targeted therapy: apoptosis
• Biology of cancer stem cells: novel therapeutic opportunities

PI: Marcel van Vugt

• DNA damage checkpoint pathways in cancer

PI: Geke Hospers

• Exploring innovative imaging techniques to visualize drug targets.

PI: An Reyners

• Gynaecological malignancies, gastrointestinal stromal tumors and palliative care

PI: Carolien Schröder

• Exploring novel rational treatment options to enhance therapeutic efficacy

PI: Annemiek Walenkamp

• Chemokines and cancer progression

Gynaecological Oncology research lines  

PI: Ate van der Zee, Head of the department of Gynaecological Oncology

PI: Bea Wisman

• Improvement of the current population-based cervical cancer screening

• Identification of novel genes and pathways in the response to therapy